Market open
CareDx/$CDNA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About CareDx
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Ticker
$CDNA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
647
ISIN
US14167L1035
Website
CareDx Metrics
BasicAdvanced
$857M
14.32
$1.07
2.28
-
Price and volume
Market cap
$857M
Beta
2.28
52-week high
$34.84
52-week low
$9.99
Average daily volume
942K
Financial strength
Current ratio
4.107
Quick ratio
3.546
Long term debt to equity
6.346
Total debt to equity
7.981
Management effectiveness
Return on assets (TTM)
-5.20%
Return on equity (TTM)
19.54%
Valuation
Price to earnings (TTM)
14.322
Price to revenue (TTM)
2.384
Price to book
2.25
Price to tangible book (TTM)
2.83
Price to free cash flow (TTM)
40.99
Growth
Revenue change (TTM)
25.92%
Earnings per share change (TTM)
-130.71%
3-year revenue growth (CAGR)
3.95%
3-year earnings per share growth (CAGR)
4.29%
What the Analysts think about CareDx
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for CareDx stock.
CareDx Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
CareDx Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
CareDx News
AllArticlesVideos
CareDx, Inc (CDNA) Q1 2025 Earnings Call Transcript
Seeking Alpha·1 week ago
CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting
Business Wire·2 weeks ago
CareDx to Report First Quarter 2025 Financial Results
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for CareDx stock?
CareDx (CDNA) has a market cap of $857M as of May 09, 2025.
What is the P/E ratio for CareDx stock?
The price to earnings (P/E) ratio for CareDx (CDNA) stock is 14.32 as of May 09, 2025.
Does CareDx stock pay dividends?
No, CareDx (CDNA) stock does not pay dividends to its shareholders as of May 09, 2025.
When is the next CareDx dividend payment date?
CareDx (CDNA) stock does not pay dividends to its shareholders.
What is the beta indicator for CareDx?
CareDx (CDNA) has a beta rating of 2.28. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.